Comprehensive profiling of TSPAN32 expression across genetically annotated patient cohorts will be necessary to delineate the precise relationship between leukemia subtype, underlying mutations (e.g., NOTCH1, FBXW7, PHF6, HOXA cluster abnormalities), and TSPAN32 regulation. Here, TSPAN32 is linked to leukemia.